According to a report in STAT News, Pfizer and Moderna have rejected US President Donald Trump's invitation to attend a White House "Vaccine Summit," as reported in This is Money.
The meeting, scheduled for December 8, will be attended by Trump, Vice President Mike Pence and private-sector executives, and comes ahead of the FDA's review of both companies' respective vaccine candidates.
Industry officials familiar with the plans for the summit interpret it as an opportunity for the White House to pressure the FDA to quickly issue emergency-use authorizations for the two candidates, the STAT News reported last week.
Invitees at the meeting include drug distributors, pharmacies and logistics companies such as McKesson, Walgreens Boots Alliance and CVS Health.
To read more NewsPoints articles, click here.